IL15 and neoplasm: Treatment with 10 μg IT MS~RLI resulted in a moderate ~42% TGI and a 76% reduction in terminal tumor weight, whereas equimolar MS~IL-15 gave only ~20% TGI and insignificant ~30% tumor weight reduction (Figure 7A; Supplementary Figure 14).